Literature DB >> 33119883

Microglia in the Brain Tumor Microenvironment.

Allison P Cole1, Eric Hoffmeyer1, Senthilnath Lakshmana Chetty1, Joselyn Cruz-Cruz1, Forrest Hamrick2, Osama Youssef2, Samuel Cheshier3, Siddhartha S Mitra1.   

Abstract

Microglia are the brain resident phagocytes that act as the primary form of the immune defense in the central nervous system. These cells originate from primitive macrophages that arise from the yolk sac. Advances in imaging and single-cell RNA-seq technologies provided new insights into the complexity of microglia biology.Microglia play an essential role in the brain development and maintenance of brain homeostasis. They are also crucial in injury repair in the central nervous system. The tumor microenvironment is complex and includes neoplastic cells as well as varieties of host and infiltrating immune cells. Microglia are part of the glioma microenvironment and play a critical part in initiating and maintaining tumor growth and spread. Microglia can also act as effector cells in treatments against gliomas. In this chapter, we summarize the current knowledge of how and where microglia are generated. We also discuss their functions during brain development, injury repair, and homeostasis. Moreover, we discuss the role of microglia in the tumor microenvironment of gliomas and highlight their therapeutic implications.

Entities:  

Keywords:  Brain tumor; CD47; Development; Glioblastoma; Glioma; Gliomagenesis; High-grade glioma; Immune therapy; M1; M2; Macrophage; Microenvironment extracellular matrix; Microglia; Pericyte

Mesh:

Year:  2020        PMID: 33119883     DOI: 10.1007/978-3-030-49270-0_11

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  3 in total

1.  Mapping the tumor-infiltrating immune cells during glioblastoma progression.

Authors:  Senthilnath Lakshmanachetty; Siddhartha S Mitra
Journal:  Nat Immunol       Date:  2022-06       Impact factor: 31.250

Review 2.  M2 Macrophages Serve as Critical Executor of Innate Immunity in Chronic Allograft Rejection.

Authors:  Hanwen Zhang; Zhuonan Li; Wei Li
Journal:  Front Immunol       Date:  2021-03-17       Impact factor: 7.561

Review 3.  Glioma: molecular signature and crossroads with tumor microenvironment.

Authors:  Lennart Barthel; Martin Hadamitzky; Philipp Dammann; Manfred Schedlowski; Ulrich Sure; Basant Kumar Thakur; Susann Hetze
Journal:  Cancer Metastasis Rev       Date:  2021-10-23       Impact factor: 9.264

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.